20(R)-Propanaxadiol
CAS No. 38243-03-7
20(R)-Propanaxadiol ( —— )
产品货号. M18496 CAS No. 38243-03-7
20(R)-Propanaxadiol 是一种具有抗衰老和抗疲劳活性的化合物。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥244 | 有现货 |
|
| 10MG | ¥392 | 有现货 |
|
| 25MG | ¥713 | 有现货 |
|
| 50MG | ¥1042 | 有现货 |
|
| 100MG | ¥1494 | 有现货 |
|
| 200MG | ¥2223 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥339 | 有现货 |
|
生物学信息
-
产品名称20(R)-Propanaxadiol
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述20(R)-Propanaxadiol 是一种具有抗衰老和抗疲劳活性的化合物。
-
产品描述R-Ginsenodie Rg3 γ2 GABA-A receptor agonist, 7.1 K+ channel activator, α10 nAChR antagonist found in Panax. It exhibits a wide variety of biological activities, including decreasing expression of pro-inflammatory cytokines, reducing oxidative stress, and inhibiting tubular formation and migration of endothelial progenitor cells.
-
体外实验——
-
体内实验Animal Model:Male Kunming mice weighing 18-22 g Dosage:0.05 mg/kg, 0.1 mg/kg, 0.5 mg/kg (5 μL each nostril) Administration:Intranasal administration; for 2 weeks Result:Significantly prolonged the weight-loaded swimming time, and also increased the hepatic glycogen levels.
-
同义词——
-
通路Cell Cycle/DNA Damage
-
靶点DNA/RNA Synthesis
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number38243-03-7
-
分子量785.02
-
分子式C42H72O13
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 41.67 mg/mL (53.08 mM)
-
SMILESC1[C@@H](C([C@H]2[C@](C1)([C@@H]1[C@@](CC2)([C@]2([C@H]([C@@H](C1)O)[C@H](CC2)[C@@](C)(CCC=C(C)C)O)C)C)C)(C)C)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)O)O)CO
-
化学全称(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-4,5-dihydroxy-2-(((3R,5S,8R,9R,10R,12S,13R,14R,17S)-12-hydroxy-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,10,13,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Bae EA,et al. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol Pharm Bull. 2002 Jan;25(1):58-63.
021-51111890
购物车()
sales@molnova.cn

